AdaBoost-powered cloud of things framework for low-latency, energy-efficient chronic kidney disease prediction

The United Nations' sustainable development agenda has set an ambitious goal of reducing premature mortality from non-communicable diseases by 33% by 2030. Among these diseases, chronic kidney disease (CKD) is a significant contributor to both morbidity and mortality. Integrating the Internet of Things (IoT) and cloud computing in healthcare has gained momentum, particularly in remote patient monitoring. However, it is essential to acknowledge that cloud computing has limitations, particularly in handling vast volumes of Big Data, mainly due to scalability and latency concerns. This article proposes a novel framework, AdaBoostCoTCKD, to mitigate latency issues, minimize response times, reduce power consumption, and optimize network resources for predicting CKD. The framework leverages the synergy between the AdaBoost machine learning technique and fog computing paradigms to enhance the precision and efficiency of CKD prediction methods. In addition, it introduces an auxiliary cloud-based database, enriching the pool of future insights and facilitating prospective database infrastructure expansions. This augmentation is expected to impact predictive accuracy positively. We conducted comprehensive experiments to demonstrate the effectiveness of our approach. Our model achieved an impressive training accuracy of 99.928% and testing accuracy of 99.975%, while the fog environment reduced latency by 31% and energy consumption by 75% compared to traditional cloud-based solutions. Our proposed system enables early CKD detection and offers advantages over cloud-only solutions, providing a robust and efficient platform for healthcare IoT applications with significant clinical value. These promising results underscore the potential of combining fog computing and the AdaBoost machine learning technique to advance healthcare by addressing latency, response time, power consumption, and network resource optimization challenges in CKD prediction.